Vt. to get $95K in drug settlement
MONTPELIER, Vt. - October 5, 2010 -- Vermont will receive $95,000 as part of a multistate settlement with a subsidiary of pharmaceutical giant Johnson & Johnson accused of promoting a drug for uses not approved by the Food and Drug Administration.
The $75 million settlement with Titusville, N.J.-based Ortho-McNeil-Janssen Pharmaceuticals Inc., involves all 50 states, the District of Columbia and the federal government.
The agreement announced Monday resolves allegations that the company promoted topiramate, an antiepileptic and migraine prevention drug marketed as Topamax 5/8, for uses not approved by the FDA, such as for bipolar disorder and drug and alcohol dependency.
johnson & johnson, vermont, new jersey, business/finance
- Parking dispute turns violent at Cherry Hill Mall
- Milder Monday
- Get the 6abc StormTracker app
- WATCH: Action News Online
- Mutilated animal found in Brewerytown
- 'Band of Brothers' vet William Guarnere dies at 90
- 1 wounded in daytime shooting in Trenton 24 min ago
- Vietnam says it may have found missing jet's door
- Mom accused of driving into surf goes before judge
- Suspect SUV in deadly hit and run caught on camera
- Residents return following Bucks Co. hazmat
- Man, 22, dies after shooting in Chester
- Video: Annual Phila. Flower Show wraps up
- Photos: $3.25M summer home in Ocean City, NJ